Search - tctmd.com

Presenter: Manolis Vavuranakis, Maria Kariori, Konstantinos Kalogeras, Dimitrios Vrachatis, Carmen Moldovan, Konstantinos Aznaouridis, Evangelia Gravia, Christodoulos Stefanadis

January 31, 2013

News Daily News

Not All Endografts Created Equal with Regard to Inflammatory Response

L.A. McKeown

January 22, 2013

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

News Conference News TCT 2012

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

October 24, 2012

News Daily News

Blood Transfusion Associated with Acute Kidney Injury in TAVR Patients

Caitlin E. Cox

October 15, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Industry News

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

July 16, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

News Daily News

Iron Chelation Therapy Fails to Prevent Reperfusion Injury After STEMI

May 02, 2012

Presentation TCTAP 2012

ACCEL-LOADING-ACS: Multicenter Randomized Trial Evaluating Efficacy of Cilostazol on Platelet aggregation, Inflammation, and Myonecrosis in ACS Patients

Presenter: Young-Hoon Jeong

April 26, 2012

News Daily News

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

Jason Kahn

April 17, 2012

Advertisement

Novel Urinary Inflammation Marker Sharpens Prognosis of Stable CAD

INFUSE-AMI Substudy: Blush Grade Key to Better Outcomes in STEMI Patients

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

Post-TAVR Hypertension Common, Predicts Better Outcomes

La Hipertensión Post-TAVR es Frecuente y Predice Mejores Resultados

Colchicine Reduces BMS Restenosis in Diabetic Patients

REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

The effect of inflammation on left ventricular function after trancatheter aortic valve implantation

Not All Endografts Created Equal with Regard to Inflammatory Response

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

Blood Transfusion Associated with Acute Kidney Injury in TAVR Patients

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

Iron Chelation Therapy Fails to Prevent Reperfusion Injury After STEMI

ACCEL-LOADING-ACS: Multicenter Randomized Trial Evaluating Efficacy of Cilostazol on Platelet aggregation, Inflammation, and Myonecrosis in ACS Patients

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content